TNF[alpha]-inhibition in the treatment of rheumatoid arthritis

Author(s)

• Moreland, Larry W
• Emery, P. (Paul)

Bibliographic Information

TNF[alpha]-inhibition in the treatment of rheumatoid arthritis

edited by Larry W. Moreland, Paul Emery

Martin Dunitz, 2003

Note

Includes bibliographical references and index

Description and Table of Contents

Description

The introduction of tumor-necrosis-factor-alpha (TNFa) blocking agents is one of the milestones in the therapy of rheumatoid arthritis (RA). Edited by Larry Moreland and Paul Emery, experts in rheumatological disease, TNFa-Inhibition in the Treatment of Rheumatoid Arthritis charts the history and development of the concept of TNFa inhibition. The authors document TNFa from its discovery to its now well-documented clinical applications in the treatment of patients with RA. They compare and contrast practical management issues concerning the use of these agents both in the US and UK/Europe. The book is a practical and accessible source containing the most recent information in this field.

Table of Contents

Definition of TNFa as a Therapeutic Target for Rheumatoid Arthritis, M. Feldman, F.M. Brennan, R.O. Williams, and R.N. Maini Infliximab Therapy, R.N. Maini and M. Feldman Etanercept, S.Sule and J.M. Bathan Adalimumab, L. van de Putte, J. Salfeld, and S. Kaymakcalan p-55 TNF Receptor Therapy, J.J. Cash TNFa-Inhibition in Practical Management of Rheumatoid Arthritis: The US Model, J.C. Shanahan and L.W. Moreland TNFa-inhibition in Practical Management: The UK/European Model, P. Emery Safety Issues with Anti-TNF Agents: Immunomodulation and Infection, J.C. Shanahan Index

by "Nielsen BookData"

Details

• NCID: BA83789426
• ISBN:
  • 1841841560
• Country Code: uk
• Title Language Code: eng
• Text Language Code: eng
• Place of Publication: London
• Pages/Volumes: viii, 180 p
• Size: 21 cm.
• Classification:
  • DC22 : 616.722706
• Subject Headings:
  • LCSH : Tumor necrosis factor
  • LCSH : Rheumatoid arthritis -- Treatment